Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gilberto Filaci is active.

Publication


Featured researches published by Gilberto Filaci.


Immunological Reviews | 1992

Theoretical and practical aspects of antigenized antibodies

Maurizio Zanetti; Frangoise Rossi; Paola Lanza; Gilberto Filaci; Richard H. Lee; Rosario Billetta

Antigenization of antibody is a new immunological concept (Zanetti 1992) that exemplifies MecthnikofTs words (Metchnikoff, reprinted in 1989) in a paradigmatic way. It was conceived with a two-fold purpose. One was to investigate directly the molecular basis of antibody antigenicity and immunogenicity. The other was to test from a molecular perspective one of the most controversial postulates ofthe idiotype network theory (Lindenmann 1973, Jeme 1974): antibodies as internal images of antigens. It soon became apparent, however, that antigenization of antibody was also a new, powerful way to provide a stable conformation to oligopeptides of general biological interest. Understanding the molecular and cellular requirements for antigenicity and immunogenicity of proteins is still a central issue in immunology. Antigenization of antibody may represent, therefore, a new alternative way to solve some of the puzzling aspects of immunology that still elude our understanding (e.g., the relationship between amino acid sequence, three-dimensional structure and function of soluble proteins and cell-surface receptors).


Journal of Physics: Conference Series | 2013

Bioactive surfaces for antibody-antigen complex detection by Atomic Force Microscopy

Vincenzo Ierardi; Francesca Ferrera; Enrico Millo; Gianluca Damonte; Gilberto Filaci; Ugo Valbusa

Recently there has been a great develop of new antibodies immobilization procedures, that keep antibodies to retain their orientation and functionality after the binding to a solid support. This allows the formation of immune-complexes useful for the detection of biomarkers from biological samples. We have developed a new method of functionalization for solid substrates that involves an initial surface activation, then a functionalization by means of 3-aminopropyltriethoxysilane-followed by another functionalization step with a layer of very small peptides, which have a high affinity to the Antibody Fc portion, acting as antibody linkers. These antibody binding peptides can immobilize the antibodies with a proper configuration that allows an unambiguous detection of antibody-antigen complexes by means of atomic force microscopy (AFM). The AFM can act as a powerful label free detection technique, which allows to detect, in principle, single molecule interactions, with the only limitation to use substrate with low-roughness surfaces; in this case, the roughness can be interpreted as background noise in the AFM analysis. Moreover, our functionalization method can be used to obtain bioactive surfaces on a wide range of solid supports, making them capable to suitably immobilize the antibodies for the antigenic binding.


Journal of the International AIDS Society | 2012

Use of maraviroc in clinical practice: a multicenter observational study

Chiara Dentone; Paolo Fraccaro; Daniela Fenoglio; E Firpo; Giovanni Cenderello; R Piscopo; Giovanni Cassola; Bartolacci; G. Casalino Finocchio; P. De Leo; Michele Guerra; G. Orofino; Eugenio Mantia; M. Zoppi; Gilberto Filaci; Alessia Parodi; A. De Maria; F. Bozzano; Francesco Marras; Maria Pia Sormani; Alessio Signori; Bianca Bruzzone; Nicola Nigro; Giuseppe Ferrea; Mauro Giacomini; Claudio Viscoli; A. Di Biagio

Promising research suggest that maraviroc (MVC) has favourable clinical outcome in HIV‐infected patients (pts). Aim of the study is to assess: durability, safety profile and immunovirological recovery in a large MVC‐based cohort.


European Journal of Immunology | 1995

Major histocompatibility complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide

Rosario Billetta; Gilberto Filaci; Maurizio Zanetti


Archive | 2009

Anti-tumor immunotherapy

Gilberto Filaci; Francesco Indiveri; Paolo Traverso


Archive | 2016

RÉCEPTEUR DE L'INTERLEUKINE 10 CHIMÉRIQUE SOLUBLE ET SON USAGE THÉRAPEUTIQUE

Gilberto Filaci; Daniela Fenoglio; Francesca Ferrera


XIII Congresso della Società Italiana di Malattie Infettive e Tropicali | 2014

Rete Ligure dell’HIV: due anni di esperienza nella gestione del dato clinico

Mauro Giacomini; Roberta Gazzarata; Barbara Giannini; E. Masi; Valeria Pupella; L. Apollaro; M. Macrì; Paolo Fraccaro; Chiara Dentone; Giovanni Cenderello; P. De Leo; G. Casalino Finocchio; Andrea De Maria; Daniela Fenoglio; Gilberto Filaci; Michele Guerra; Maurizio Setti; G. Mazzarello; A. Di Biagio; Eugenio Mantia; G. Orofino; Marco Anselmo; Giuseppe Ferrea; Giovanni Cassola; Claudio Viscoli


XIII Congresso della Società Italiana di Malattie Infettive e Tropicali | 2014

Valutazione di parametri di immunità innata e di infiammazione correlati ad aspetti clinico-metabolici in una coorte di pazienti HIV positivi con carica virale non rilevabile

Chiara Dentone; Daniela Fenoglio; Alessio Signori; Giovanni Cenderello; Alessia Parodi; F. Bozzano; Michele Guerra; P. De Leo; Valentina Bartolacci; Eugenio Mantia; M. Zoppi; G. Orofino; Francesca Kalli; Francesco Marras; Paolo Fraccaro; Mauro Giacomini; Giovanni Cassola; Bianca Bruzzone; Giuseppe Ferrea; Claudio Viscoli; Gilberto Filaci; A. De Maria; A. Di Biagio


Archive | 2010

cancer T lymphocytes in patients with + Frequency of telomerase-specific CD8

Maurizio Zanetti; Francesco Indiveri; Massimo Ghio; Umberto Benatti; Gianluca Damonte; Jean Louis Ravetti; Giorgio Carmignani; Simone Negrini; Francesca Ferrera; Andrea Romagnoli; M. Basso; Paola Contini; Marta Rizzi; Gilberto Filaci; Marco Fravega; Maurizio Setti; Paolo Traverso; Enrico Millo; Daniela Fenoglio


Archive | 2010

Transfusions Blood Possible Key to Explain the Immunomodulatory Effects of Allogeneic Soluble HLA Class I, HLA Class II, and Fas Ligand in Blood Components: A

Massimo Ghio; Paola Contini; Clemente Mazzei; Sabrina Brenci; Giuseppe Barberis; Gilberto Filaci; Francesco Indiveri; Francesco Puppo

Collaboration


Dive into the Gilberto Filaci's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Giuseppe Ferrea

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge